This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2006 Nov;24(5):481-7.

doi: 10.1007/s00345-006-0112-0.

Treatment options for BCG failures

Michael A O'Donnell¹, Andreas Boehle

Affiliations

PMID: 17021823
DOI: 10.1007/s00345-006-0112-0

Review

Treatment options for BCG failures

Michael A O'Donnell et al. World J Urol. 2006 Nov.

. 2006 Nov;24(5):481-7.

doi: 10.1007/s00345-006-0112-0.

Authors

Michael A O'Donnell¹, Andreas Boehle

Affiliation

¹ Department of Urology, University of Iowa, 200 Hawkins Dr., 3 RCP, Iowa City, IA 52242-1089, USA. michael-odonnell@uiowa.edu

PMID: 17021823
DOI: 10.1007/s00345-006-0112-0

No abstract available

PubMed Disclaimer

Similar articles

Radical cystectomy for BCG failure: has the timing improved in recent years?
Brausi M. Brausi M. BJU Int. 2011 Jul;108(2):186. doi: 10.1111/j.1464-410X.2011.10439.x. BJU Int. 2011. PMID: 21718431 No abstract available.
Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer.
Turker P, Turkeri L. Turker P, et al. Arch Esp Urol. 2013 Nov;66(9):833-40. Arch Esp Urol. 2013. PMID: 24231293 Review. English, Spanish.
Radical cystectomy for BCG failure: has the timing improved in recent years?
Soloway MS, Hepps D, Katkoori D, Ayyathurai R, Manoharan M. Soloway MS, et al. BJU Int. 2011 Jul;108(2):182-5. doi: 10.1111/j.1464-410X.2010.09830.x. Epub 2010 Nov 10. BJU Int. 2011. PMID: 21070578
[Treatment of bladder tumors].
Njinou B, Dardenne B, Darimont M, Wese FX, Van Cangh PJ. Njinou B, et al. Acta Urol Belg. 1999;67(1):6-10. Acta Urol Belg. 1999. PMID: 10859816 Review. Dutch. No abstract available.
Valrubicin: an alternative to radical cystectomy for carcinoma in situ of the bladder.
Randall S. Randall S. Urol Nurs. 2001 Feb;21(1):30-1, 34-6. Urol Nurs. 2001. PMID: 11998112 Review.

See all similar articles

Cited by

BCG-induced cytokine release in bladder cancer cells is regulated by Ca²⁺ signaling.
Ibarra C, Karlsson M, Codeluppi S, Varas-Godoy M, Zhang S, Louhivuori L, Mangsbo S, Hosseini A, Soltani N, Kaba R, Kalle Lundgren T, Hosseini A, Tanaka N, Oya M, Wiklund P, Miyakawa A, Uhlén P. Ibarra C, et al. Mol Oncol. 2019 Feb;13(2):202-211. doi: 10.1002/1878-0261.12397. Epub 2018 Dec 13. Mol Oncol. 2019. PMID: 30358081 Free PMC article.
CUA guidelines on the management of non-muscle invasive bladder cancer.
Kassouf W, Traboulsi SL, Kulkarni GS, Breau RH, Zlotta A, Fairey A, So A, Lacombe L, Rendon R, Aprikian AG, Siemens DR, Izawa JI, Black P. Kassouf W, et al. Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E690-704. doi: 10.5489/cuaj.3320. Epub 2015 Oct 13. Can Urol Assoc J. 2015. PMID: 26664503 Free PMC article. No abstract available.
Treatment options in non-muscle-invasive bladder cancer after BCG failure.
Brooks NA, O'Donnell MA. Brooks NA, et al. Indian J Urol. 2015 Oct-Dec;31(4):312-9. doi: 10.4103/0970-1591.166475. Indian J Urol. 2015. PMID: 26604442 Free PMC article. Review.
OncoTherad^® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway.
Alonso JCC, de Souza BR, Reis IB, de Arruda Camargo GC, de Oliveira G, de Barros Frazão Salmazo MI, Gonçalves JM, de Castro Roston JR, Caria PHF, da Silva Santos A, de Freitas LLL, Billis A, Durán N, Fávaro WJ. Alonso JCC, et al. Int J Mol Sci. 2023 Dec 15;24(24):17535. doi: 10.3390/ijms242417535. Int J Mol Sci. 2023. PMID: 38139364 Free PMC article. Clinical Trial.
Pharmacologic Therapies for Non-Muscle Invasive Bladder Cancer: Current and Future Treatments.
Goldberg IP, Lichtbroun B, Singer EA, Ghodoussipour S. Goldberg IP, et al. Arch Pharmacol Ther. 2022;4(1):13-22. Arch Pharmacol Ther. 2022. PMID: 36051251 Free PMC article.

See all "Cited by" articles

References

1. Br J Urol. 1993 Nov;72(5 Pt 2):744-8 - PubMed
1. J Urol. 2003 May;169(5):1706-8 - PubMed
1. Urology. 2005 Dec;66(6 Suppl 1):64-74 - PubMed
1. BJU Int. 2005 Dec;96(9):1290-3 - PubMed
1. Urology. 2000 May;55(5):673-8 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information